Dana Hilt
Förmögenhet: 974 000 $ per 2026-09-30
Förmögenhet: 974 000 $ per 2026-09-30
Dr. Dana C.
Hilt, MD, is a Chief Medical Officer at Actinogen Medical Ltd. Dr. Hilt was previously employed as a Chief Medical Officer by Frequency Therapeutics, Inc., a Chief Medical Officer by Lysosomal Therapeutics, Inc., a Chief Medical Officer by Critical Therapeutics, Inc., a Chief Medical Officer & SVP-Drug Development by FORUM Pharmaceuticals, Inc., a Director-Clinical Neurosciences by Amgen, Inc., a Chief Medical Officer by Ascend Pharmaceuticals, Inc., a Chief Medical Officer & SVP-Clinical Research by ASCEND Therapeutics US LLC, a Chief Medical Officer by Brenig Therapeutics, Inc., and a Vice President-Clinical Research by Guilford Pharmaceuticals, Inc. He received his undergraduate degree from the University of Maine and a doctorate degree from Tufts University School of Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-08-08 | 25 000 000 ( 0,65 % ) | 974 000 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| ACTINOGEN MEDICAL LIMITED | Teknisk/Vetenskaplig/F&U Direktör | 2023-02-01 |
| Företag | Position | Slut |
|---|---|---|
Brenig Therapeutics, Inc.
Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Teknisk/Vetenskaplig/F&U Direktör | 2025-06-10 |
Lysosomal Therapeutics, Inc.
Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Teknisk/Vetenskaplig/F&U Direktör | 2019-08-01 |
Critical Therapeutics, Inc.
Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Teknisk/Vetenskaplig/F&U Direktör | 2007-09-25 |
ASCEND Therapeutics US LLC
ASCEND Therapeutics US LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company develops hormone therapies | Teknisk/Vetenskaplig/F&U Direktör | - |
| KORRO BIO, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 12 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Health Technology |
Critical Therapeutics, Inc.
Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Health Technology |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
University of Maine
University of Maine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinogen Medical Ltd.
Actinogen Medical Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and develops biotechnology compounds | Health Technology |
Ascend Pharmaceuticals, Inc. | |
ASCEND Therapeutics US LLC
ASCEND Therapeutics US LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company develops hormone therapies | Health Technology |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lysosomal Therapeutics, Inc.
Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Health Technology |
Frequency Therapeutics, Inc.
Frequency Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company which develops small molecule drugs to repair damage caused by degenerative diseases | Health Technology |
Brenig Therapeutics, Inc.
Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån